Literature DB >> 15043312

Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity.

Hsuan-Ying Huang1, Marc Ladanyi, Robert A Soslow.   

Abstract

Endometrial stromal tumors (ESTs), including low-grade endometrial stromal sarcomas (LGESSs) and endometrial stromal nodules (ESNs) of classic histology, exhibit characteristic morphologic features and contain the nonrandom t(7;17)(p15; q21), which results in the fusion of two novel genes, JAZF1 and JJAZ1. ESTs may pose diagnostic challenges when they involve extrauterine sites, present as metastases, or display variant histologic appearances. The aim of this study was to evaluate the frequency of the JAZF1-JJAZ1 gene fusion among primary uterine, metastatic, and primary extrauterine ESTs of various histologic types and its role as a possible diagnostic adjunct. Using a nonnested reverse transcriptase-polymerase chain reaction approach, we assayed for JAZF1-JJAZ1 gene fusion transcripts in 10 cases with available fresh-frozen tissue. These included five primary uterine (two classic, one mixed smooth muscle, and one epithelioid LGESS; one classic ESN), four metastatic (two fibromyxoid, one classic, and one epithelioid LGESS), and one extrauterine (classic LGESS) tumor. The same primer set and assay conditions were used on five additional paraffin-embedded cases with adequate RNA, including three primary uterine (one fibromyxoid and one mixed smooth muscle LGESS; 1 mixed smooth muscle ESN) and two intraabdominal recurrent (two mixed smooth muscle LGESSs) ESTs. Two cellular leiomyomas and one ESS cell line (ESS-1) without the t(7;17) at the cytogenetic level were run in parallel as controls. JAZF1-JJAZ1 gene fusion transcripts were detected in five (33%) of 15 ESTs, including three of eight primary uterine, one of four metastatic, one of one extrauterine, and none of two recurrent cases. Most ESTs of classic histology showed evidence of JAZF1-JJAZ1 fusion (4 of 5 cases), whereas only one mixed smooth muscle ESN of 10 variant cases was positive. Positivity for JAZF1-JJAZ1 fusion transcripts was found in four of 10 fresh-frozen samples and in one of five paraffin-embedded ESTs. The control specimens were all negative. In conclusion, our data suggest that ESTs are genetically heterogeneous, with the prevalence of the JAZF1-JJAZ1 fusion being highest among ESTs of classic histology. Hence, the diagnostic utility of a JAZF1-JJAZ1 fusion transcript assay in ESTs may be limited to the classic histologic subset.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043312     DOI: 10.1097/00000478-200402000-00010

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  19 in total

1.  Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.

Authors:  Lien N Hoang; Amandeep Aneja; Niamh Conlon; Deborah F Delair; Sumit Middha; Ryma Benayed; Martee L Hensley; Kay J Park; Travis J Hollmann; Meera R Hameed; Cristina R Antonescu; Robert A Soslow; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

Review 2.  JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue.

Authors:  Andelko Hrzenjak; Farid Moinfar; Fattaneh A Tavassoli; Bettina Strohmeier; Marie-Luise Kremser; Kurt Zatloukal; Helmut Denk
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

Review 3.  Practical issues related to uterine pathology: endometrial stromal tumors.

Authors:  Marisa R Nucci
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 4.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

5.  Extrauterine endometrial stromal sarcoma with JAZF1/JJAZ1 fusion confirmed by RT-PCR and interphase FISH presenting as an inguinal tumor.

Authors:  Katsuaki Sato; Yoshimichi Ueda; Junichi Sugaya; Mamoru Ozaki; Masanori Hisaoka; Shogo Katsuda
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

6.  Molecular profiling of endometrial malignancies.

Authors:  Norasate Samarnthai; Kevin Hall; I-Tien Yeh
Journal:  Obstet Gynecol Int       Date:  2010-03-28

7.  Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.

Authors:  Cheng-Han Lee; Rola H Ali; Marjan Rouzbahman; Adrian Marino-Enriquez; Meijun Zhu; Xiangqian Guo; Alayne L Brunner; Sarah Chiang; Samuel Leung; Nataliya Nelnyk; David G Huntsman; C Blake Gilks; Torsten O Nielsen; Paola Dal Cin; Matt van de Rijn; Esther Oliva; Jonathan A Fletcher; Marisa R Nucci
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

Review 8.  Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques.

Authors:  Patricia Baker; Esther Oliva
Journal:  J Clin Pathol       Date:  2007-03       Impact factor: 3.411

9.  Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes.

Authors:  Andres M Acosta; Lynette M Sholl; Brendan C Dickson; Jesse K McKenney; Jennifer B Gordetsky; Michael R Pins; Adrian Marino-Enriquez; Fei Dong; Adrian M Dubuc; Paola Dal Cin; Christopher D M Fletcher
Journal:  Mod Pathol       Date:  2021-05-13       Impact factor: 7.842

10.  Identification and characterization of renal cell carcinoma gene markers.

Authors:  Gul S Dalgin; Dustin T Holloway; Louis S Liou; Charles DeLisi
Journal:  Cancer Inform       Date:  2007-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.